Are Clinical Trials Agile Enough? What Pharma can Learn from Software Development
With product development life-cycles often in excess of 10 years, drug developers must bring to market products that are not just competitively differentiated in the current landscape, but that will also be competitively differentiated and of value to the patient when compared against an unknown future standard of care. Jeffrey Handen at Medidata Solutions Worldwide describes how this paradigm creates inherent risks and necessitates surveying the environment constantly in order to rapidly adjust to new competitive threats and scientific opportunities.
http://jforcs.com/jcs/wp-content/uploads/edd/2012/11/2-Are-Clinical-Trials-Agile-Enough-What-Pharma-Can-Learn-from-Software-Development.pdf